Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Sci Rep ; 11(1): 4988, 2021 03 02.
Article in English | MEDLINE | ID: mdl-33654223

ABSTRACT

Mobile Stroke Unit (MSU) expedites the delivery of intravenous thrombolysis in acute stroke patients. We further evaluated the functional outcome of patients shipped to a tertiary care centre or repatriated to local hospitals after triage by MSU in acute stroke syndrome in rural northern Alberta. Consecutive patients with suspected acute stroke syndrome were included. On the basis of neurology consultation and, Computed Tomography findings, patients, who were thrombolysed or needed advanced care were transported to the Comprehensive stroke center (CSC) (Triage to CSC group). Other patients were repatriated to local hospital care (Triage to LHC group). A total of 156 patients were assessed in MSU, 73 (46.8%) were female and the mean age was 66.6 ± 15 years. One hundred and eight (69.2%) patients, including 41 (26.3%) treated with thrombolysis were transported to the CSC (Triage to CSC group) and 48 (30.8%) were repatriated to local hospital care. The diagnosis made in MSU and final diagnosis were matching in 88% (95) and 91.7% (44, p = 0.39) in Triage to CSC and Triage to LHC groups respectively. Prehospital triage by MSU of acute stroke syndrome can reliably repatriate patients to the home hospital. The proposed model has the potential to triage patients according to their medical needs by enabling treatment in home hospitals whenever reasonable.


Subject(s)
Emergency Medical Services , Mobile Health Units , Stroke/diagnostic imaging , Stroke/diagnosis , Tomography, X-Ray Computed , Triage , Aged , Aged, 80 and over , Alberta , Female , Humans , Male , Middle Aged , Stroke/therapy , Thrombolytic Therapy , Time-to-Treatment
3.
Front Neurol ; 10: 1417, 2019.
Article in English | MEDLINE | ID: mdl-32116989

ABSTRACT

Background: A rapid and reliable method to predict significant early hematoma growth in the acute setting is of great important to better inform clinicians and researchers in their efforts to improve outcomes for patients. Methods: We established a 10-point score system to predict hematoma growth including four parameters: baseline intracerebral hemorrhage (ICH) volume > 30 mL, time to initial CT scan ≤ 3 h, island sign and black hole sign. Then, we reviewed our ICH database and assessed the predict value of the score system. Results: A total of 216 ICH patients were included. Patients with hematoma growth at 24 h had higher score than those without hematoma growth (7.6 ± 3.0 vs. 2.0 ± 2.4, p < 0.001). The optimal cut-off value of the score for predicting hematoma growth was 3 (area under curve, 0.937; 95% CI, 0.899-0.975, p < 0.001), with 95% CI of 0.896-0.965 in bootstrapping analysis. The sensitivity, specificity, positive predictive and negative predictive value of the score ≥ 3 for predicting hematoma growth were 97.8, 92.7, 90.9, and 98.3%. Conclusion: The 10-point score system could predict hematoma growth with high accuracy.

4.
Can J Cardiol ; 34(11): 1503-1511, 2018 11.
Article in English | MEDLINE | ID: mdl-30404753

ABSTRACT

Atrial fibrillation (AF) is numerically the most important risk factor for stroke. It is well established that patients with AF have a 5-fold increased risk of stroke relative to those without and that anticoagulation reduces the risk of stroke by approximately two-thirds. Definitively attributing the mechanism of an individual stroke to AF is more problematic, however. In fact, there is no way to reliably establish the etiology of any ischemic infarction. This necessitates screening for all potential stroke risk factors and treating accordingly. The pattern of infarction is often used to classify the presumed mechanism of infarction as thrombotic or embolic, although even this is approach is based on association and increasingly is recognized as not completely reliable. Furthermore, it should not dictate management-patients with perforating arterial territory infarcts with AF also require and benefit from anticoagulation. Likewise, if other potential embolic sources beyond AF are identified, anticoagulation remains the standard of care. The traditional conceptual model of the mechanistic link between AF and cardioembolic infarction is likely oversimplified. Long-term cardiac rhythm recording studies indicate an inconsistent temporal relationship between AF and infarction. This suggests that cardioembolic stroke in patients with AF may result from the underlying atrial cardiopathy, rather than the rhythm disturbance leading to atrial stasis and thromboembolism. We reviewed traditional and current concepts, as well as evidence for the role of AF in ischemic stroke.


Subject(s)
Atrial Fibrillation/physiopathology , Stroke/physiopathology , Cardiomyopathies/physiopathology , Cerebral Small Vessel Diseases/physiopathology , Endothelium, Vascular/physiopathology , Fibrosis , Heart Atria/pathology , Heart Atria/physiopathology , Humans , Inflammation/physiopathology , Thromboembolism/physiopathology , Thrombophilia/physiopathology
5.
Transl Stroke Res ; 9(3): 283, 2018 06.
Article in English | MEDLINE | ID: mdl-29330712

ABSTRACT

The author names "Dr. Pablo Garcia Bermejo" and "Dr. Muhammad Faisal Wadiwala" needed to be added as the 6th and 7th authors, respectively. The authors regret this error.

6.
Transl Stroke Res ; 9(3): 274-282, 2018 06.
Article in English | MEDLINE | ID: mdl-29101611

ABSTRACT

Asymptomatic small vessel disease (SVD), including white matter hyperintensities (WMHIs), periventricular hyperintensities (PVHIs), silent stroke (SS), and cerebral microbleeds (CMBs), increases the risk of stroke. There are limited studies of SVD in subjects from the Middle East and Southeast Asia (SA). All patients admitted to stroke service between 2014 and 2015 were reviewed for presence of "pre-existing" SVD. Stroke mimics with no previous history of stroke were used as controls. There were 1727 patients admitted with stroke. Analysis was done on 988 subjects (914 strokes and 74 controls) who had MRI scan done. Pre-existing SVD was seen in 642 (64.9%) patients (WMHIs 19.6%, PVHIs 33.2%, SS 51.4%, and CMBs 22%). Silent strokes were significantly more common with ischemic stroke (IS) compared to intracranial hemorrhage (ICH) (62.0 vs 34.3%, p < 0.001). CMBs were more in ICH compared to IS (42.9 vs 23.1%, p < 0.001). The risk of developing CMBs among Far Eastern (FE) patients was 1.58 times more (p = 0.07), while 1.48 times more in Arabs (AR) (p = 0.026) compared to SA after adjusting for age. The risk of developing PVHIs was significantly higher in Arab compared to SA (odds ratio (OR) 1.43; p value = 0.021). Similarly, the risk of developing WMHIs was also significantly higher in AR patients (OR 1.6; p value = 0.009) compared to SA. The majority of ethnic AR, SA, and FE populations show pre-existing SVD on MRI. The advanced changes at a young age may be related to high prevalence of untreated risk factors and possibly as yet defined genetic and environmental factors.


Subject(s)
Brain Ischemia/epidemiology , Cerebral Small Vessel Diseases/epidemiology , Intracranial Hemorrhages/epidemiology , Leukoencephalopathies/epidemiology , Stroke/epidemiology , Adult , Aged , Asia, Southeastern/epidemiology , Brain Ischemia/diagnostic imaging , Cerebral Small Vessel Diseases/diagnostic imaging , Asia, Eastern/epidemiology , Female , Humans , Intracranial Hemorrhages/diagnostic imaging , Leukoencephalopathies/diagnostic imaging , Magnetic Resonance Imaging , Male , Middle Aged , Middle East/epidemiology , Philippines/epidemiology , Stroke/diagnostic imaging
7.
Transl Stroke Res ; 7(6): 458-477, 2016 12.
Article in English | MEDLINE | ID: mdl-27586681

ABSTRACT

Treatment of hypertension, diabetes, high cholesterol, smoking cessation, and healthy lifestyle have all contributed to the decline in the incidence of vascular disease over the last several decades. Patients who suffer an acute stroke are at a high risk for recurrence. Introduction of newer technologies and their wider use allows for better identification of patients in whom the risk of recurrence following an acute stroke may be very high. Traditionally, the major focus for diagnosis and management has focused on patient history, examination, imaging for carotid stenosis/occlusion, and detection of AF and paroxysmal AF (PAF) with 24-48 h cardiac monitoring. This review focuses on the usefulness of three newer investigative tools that are becoming widely available and lead to better prevention. Continuous ambulatory blood pressure measurements for 24 h or longer and 3D Doppler measures of the carotid arteries provide key useful information on the state of vascular health and enhance our ability to monitor the response to preventive therapies. Furthermore, the detection of PAF can be significantly improved with prolonged cardiac monitoring for 3 weeks or longer, enabling the initiation of appropriate prevention therapy. This review will focus on the potential impact and importance of these emerging technologies on the prevention of recurrent stroke in high-risk patients.


Subject(s)
Disease Management , Secondary Prevention/methods , Stroke/diagnosis , Stroke/prevention & control , Animals , Blood Pressure Monitoring, Ambulatory/methods , Humans , Recurrence
8.
J Stroke Cerebrovasc Dis ; 25(8): 2043-6, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27256170

ABSTRACT

BACKGROUND AND PURPOSE: To assess the effect of acute thrombolysis protocol on "door-to-needle time" (DTN) and improvement in outcome following acute stroke (AS). METHODS: The charts of all patients receiving intravenous (IV) thrombolysis for AS between January 2008 and June 2015 were reviewed for DTN, complications, and clinical outcome. Good prognosis was defined as modified Rankin Scale (mRS) score of less than 2 at 90 days. In January 2014, a protocol for faster DTN was introduced. We reviewed the prognosis before and after the introduction of the new protocol. RESULTS: Up to 204 patients received IV recombinant tissue plasminogen activator (r-tPA) (mean age 52.5 ± 12.4 years). Mean door-to-CT time improved from 42.5 ± 41.1 to 27.1 ± 26.3 minutes (P < .001); DTN improved from 83.26 ± 47.7 to 47.09 ± 25.7 minutes (P < .001). Complications were reduced from 15.7% to 8.8% (P = .14). The mRS score of less than or equal to 2 improved from 47.1% to 73.3% at 90 days (P = .001). After implementing new protocol, thrombolysis rate increased to 11.8% in 2014 (before 3.3% in 2011, 4.9% in 2012, and 4.4% in 2013), P < .0001. NIHSS (National Institutes of Health Stroke Scale) score at admission (P = .002), hypodensity on initial CT brain (P = .041), protocol implementation (P = .014), and reduced length of stay (P = .004) were associated with outcome at 90 days (mRS score ≤2). CONCLUSION: Implementation of specific protocols to reduce DTN in patients receiving IV r-tPA leads to reduction in complications and improves outcome.


Subject(s)
Stroke/drug therapy , Time-to-Treatment , Treatment Outcome , Adult , Aged , Female , Fibrinolytic Agents/therapeutic use , Humans , Male , Middle Aged , Qatar/epidemiology , Retrospective Studies , Tertiary Care Centers , Time Factors , Tissue Plasminogen Activator
9.
Stroke ; 46(12): 3494-501, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26493677

ABSTRACT

BACKGROUND AND PURPOSE: Usefulness of multidisciplinary stroke units in acute stroke patients is well established. There is extensive western literature on usefulness of stroke units in outcome, but limited evidence from the rest of the world. We aim to evaluate the impact of establishing a stroke unit on outcome in patients presenting to a tertiary care facility. METHODS: This is a retrospective study of 1003 patients with acute stroke admitted to Hamad General Hospital, Qatar, between January 2014 and February 2015. Patients directly admitted to intensive care unit (132) were excluded. We compared outcomes of pre- and poststroke ward (SW) establishment and in SW patients versus those of general medical wards. RESULTS: Before the establishment of the SW, 175 patients were admitted to the hospital. From April 2014 to February 2015, 696 patients were admitted (SW, 545; medical ward, 151). There was a significant reduction in length of stay from 14.7±27.7 to 6.2±20.2 days (P=0.0001) and incidence of complications (23.6% versus 6.4%, P=0.0001) after implementation of stroke-specific protocols. Prognosis at discharge (modified Rankin Scale 0-2 in 56.0% versus 70.4%, P=0.001) and at 90 days (modified Rankin Scale 0-2 in 70.6% versus 95.0%, P=0.001) also significantly improved. Compared with medical ward patients, outcome was significantly better in SW patients with fewer complications (10.9% versus 5.0%, P=0.013) and shorter length of stay (8.9±30.7 versus 5.4±16.1 days, P=0.05). CONCLUSIONS: Establishing a distinct SW is essential for achieving full benefits of stroke protocols implementation. SW patients have significantly fewer complications and better prognosis when compared with patients in medical wards.


Subject(s)
Hospital Units , Hospitalization , Stroke/diagnosis , Stroke/therapy , Adult , Aged , Female , Hospital Units/trends , Hospitalization/trends , Hospitals, General/methods , Hospitals, General/trends , Humans , Male , Middle Aged , Prospective Studies , Qatar/epidemiology , Retrospective Studies , Stroke/epidemiology , Treatment Outcome
10.
Mult Scler ; 19(6): 816-9, 2013 May.
Article in English | MEDLINE | ID: mdl-22968545

ABSTRACT

No published epidemiologic data on multiple sclerosis (MS) in Qatar exist. Our objectives were to determine the prevalence, demographics and clinical characteristics of MS in the Middle Eastern country of Qatar. We analyzed data for Qatari MS patients fulfilling the McDonald diagnostic criteria. A total of 154 patients fulfilled the inclusion criteria. On 31 April 2010, the crude prevalence of MS in Qatar was 64.57 per 100,000 inhabitants (95% CI: 58.31-70.37). The female-to-male ratio was 1.33:1. A positive family history was found in 10.4% of included MS patients. We conclude that Qatar is now a medium-to-high risk area for MS, with some important differences in clinical characteristics as compared to other countries in the region.


Subject(s)
Multiple Sclerosis/epidemiology , Adolescent , Adult , Age of Onset , Child , Female , Humans , Male , Middle Aged , Multiple Sclerosis/diagnosis , Prevalence , Prospective Studies , Qatar/epidemiology , Retrospective Studies , Risk Factors , Sex Distribution , Sex Factors , Young Adult
11.
J Neurol Sci ; 323(1-2): 250-3, 2012 Dec 15.
Article in English | MEDLINE | ID: mdl-22982000

ABSTRACT

We describe a patient presenting with vertical one-and-a-half syndrome and concomitant contralesional horizontal gaze paresis as the result of a solitary neurocysticercosis (NCC) lesion in the right midbrain extending into the thalamomesencephalic junction. The patient received an albendazole-dexamethasone course which resulted in resolution of his symptoms. The neuro-ophthalmological complications of NCC are reviewed and the clinical topography of the neuro-ophthalmological findings of this unusual observation are discussed.


Subject(s)
Diplopia/etiology , Neurocysticercosis/complications , Nystagmus, Pathologic/etiology , Ocular Motility Disorders/etiology , Oculomotor Nerve Diseases/etiology , Abducens Nerve Diseases/diagnosis , Adult , Albendazole/therapeutic use , Anthelmintics/therapeutic use , Blepharoptosis/etiology , Dexamethasone/therapeutic use , Diagnosis, Differential , Diplopia/drug therapy , Drug Therapy, Combination , Headache/etiology , Humans , Male , Mesencephalon/parasitology , Mesencephalon/physiopathology , Neurocysticercosis/diagnosis , Neurocysticercosis/drug therapy , Neurocysticercosis/physiopathology , Nystagmus, Pathologic/drug therapy , Ocular Motility Disorders/drug therapy , Oculomotor Nerve Diseases/diagnosis , Oculomotor Nerve Diseases/drug therapy , Oculomotor Nerve Diseases/parasitology , Reflex, Abnormal , Thalamus/parasitology , Thalamus/physiopathology
13.
Rev Med Chil ; 138(2): 217-9, 2010 Feb.
Article in Spanish | MEDLINE | ID: mdl-20461311

ABSTRACT

Hemi paretic ataxia (HA) is a lacunars syndrome that presents with motor deficit and pyramidalism associated to ipsilateral ataxia out of proportion to such deficit. Topography of lesions is wide and acute infarcts have been recognized at the infernal capsule, pons, thalamus, corona radiate and cortex. Symptoms are associated to involvement of pyramidal and corticopontocerebellar tracts. We report a 44-year-old mole presenting with right hemi paresis and severe ataxia. The magnetic resonance imaging showed a sub acute infarction of the left lenticular nucleus and infernal capsule. The patient was treated with physiotherapy, anti platelet agents and statins and was discharged with an evident recovery.


Subject(s)
Ataxia/etiology , Cerebral Infarction/complications , Paresis/drug therapy , Adult , Ataxia/drug therapy , Cerebral Infarction/drug therapy , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Internal Capsule/blood supply , Magnetic Resonance Imaging , Male , Paresis/etiology , Platelet Aggregation Inhibitors/therapeutic use , Severity of Illness Index
14.
Rev. méd. Chile ; 138(2): 217-219, feb. 2010. ilus
Article in Spanish | LILACS | ID: lil-546214

ABSTRACT

Hemi paretic ataxia (HA) is a lacunars syndrome that presents with motor deficit and pyramidalism associated to ipsilateral ataxia out of proportion to such deficit. Topography of lesions is wide and acute infarcts have been recognized at the infernal capsule, pons, thalamus, corona radiate and cortex. Symptoms are associated to involvement of pyramidal and corticopontocerebellar tracts. We report a 44-year-old mole presenting with right hemi paresis and severe ataxia. The magnetic resonance imaging showed a sub acute infarction of the left lenticular nucleus and infernal capsule. The patient was treated with physiotherapy, anti platelet agents and statins and was discharged with an evident recovery.


Subject(s)
Adult , Humans , Male , Ataxia/etiology , Cerebral Infarction/complications , Paresis/drug therapy , Ataxia/drug therapy , Cerebral Infarction/drug therapy , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Internal Capsule/blood supply , Magnetic Resonance Imaging , Paresis/etiology , Platelet Aggregation Inhibitors/therapeutic use , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...